UY39705A - Novedosos compuestos útiles como agonistas de sting y sus usos - Google Patents

Novedosos compuestos útiles como agonistas de sting y sus usos

Info

Publication number
UY39705A
UY39705A UY0001039705A UY39705A UY39705A UY 39705 A UY39705 A UY 39705A UY 0001039705 A UY0001039705 A UY 0001039705A UY 39705 A UY39705 A UY 39705A UY 39705 A UY39705 A UY 39705A
Authority
UY
Uruguay
Prior art keywords
novel compounds
compounds useful
sting agonists
compounds
sting
Prior art date
Application number
UY0001039705A
Other languages
English (en)
Spanish (es)
Inventor
Wei Long
Yanping Wang
Yang Ye
Xiuwei Li
Guiqun Yang
Fashun Yan
Original Assignee
Jacobio Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jacobio Pharmaceuticals Co Ltd filed Critical Jacobio Pharmaceuticals Co Ltd
Publication of UY39705A publication Critical patent/UY39705A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
UY0001039705A 2021-03-30 2022-03-29 Novedosos compuestos útiles como agonistas de sting y sus usos UY39705A (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
CN2021083783 2021-03-30
CN2021090945 2021-04-29
CN2021111479 2021-08-09
CN2021128942 2021-11-05
CN2021130097 2021-11-11
CN2021138806 2021-12-16
CN2021143043 2021-12-30
CN2022071548 2022-01-12

Publications (1)

Publication Number Publication Date
UY39705A true UY39705A (es) 2022-10-31

Family

ID=83457956

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001039705A UY39705A (es) 2021-03-30 2022-03-29 Novedosos compuestos útiles como agonistas de sting y sus usos

Country Status (8)

Country Link
US (1) US20240116909A1 (https=)
EP (1) EP4313962A4 (https=)
JP (1) JP2024511832A (https=)
CN (1) CN117203194A (https=)
AR (1) AR125608A1 (https=)
TW (1) TW202302579A (https=)
UY (1) UY39705A (https=)
WO (1) WO2022206725A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118524854A (zh) * 2021-12-17 2024-08-20 北京加科思新药研发有限公司 包含可用作sting激动剂的新型化合物的化合物-连接基构建体及其用途
WO2024032782A1 (en) * 2022-08-12 2024-02-15 Jacobio Pharmaceuticals Co.Ltd. Vaccine adjuvants and uses thereof
WO2026001915A1 (en) * 2024-06-24 2026-01-02 Jacobio Pharmaceuticals Co., Ltd. Drug linker, conjugate thereof, and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3774765A4 (en) * 2018-04-03 2021-12-29 Merck Sharp & Dohme Corp. Aza-benzothiophene compounds as sting agonists
JP7326319B2 (ja) * 2018-04-03 2023-08-15 メルク・シャープ・アンド・ドーム・エルエルシー Stingアゴニストとしてのベンゾチオフェン類及び関連する化合物
CR20220029A (es) * 2019-07-22 2022-03-14 Lupin Ltd Compuestos macrocíclicos como agonistas de sting y métodos y usos de los mismos

Also Published As

Publication number Publication date
CN117203194A (zh) 2023-12-08
JP2024511832A (ja) 2024-03-15
AR125608A1 (es) 2023-08-02
TW202302579A (zh) 2023-01-16
WO2022206725A1 (en) 2022-10-06
EP4313962A1 (en) 2024-02-07
US20240116909A1 (en) 2024-04-11
EP4313962A4 (en) 2025-02-26

Similar Documents

Publication Publication Date Title
NI201900029A (es) COMPUESTOS DE BENZO[b]TIOFENO COMO AGONISTAS DE STING
UY39705A (es) Novedosos compuestos útiles como agonistas de sting y sus usos
EA201890450A1 (ru) Циклические динуклеотидные соединения в качестве агонистов sting
CL2021002519A1 (es) Compuestos de diazina-amida activos como pesticidas.
MX2021012162A (es) Compuestos de diazina-amida activos como pesticidas.
CY1125004T1 (el) Ετεροαρυλο υποκατεστημενες βητα-υδροξυαιθυλαμινες για χρηση στη θεραπεια της υπεργλυκαιμιας
UY38366A (es) Compuestos de azol-amida pesticidamente activos
MX2022001158A (es) Inhibidores dobles de atm y adn-pk para uso en terapias antitumorales.
MX2019001096A (es) Antagonistas del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos.
PY1923494A (es) Derivados de n-(3-(7h-pirrolo[2,3-d]pirimidin-4-il)fenil)benzamida
CO6361936A2 (es) Imidazopiridazinacarbonitrilos utiles como inhibidores de quinasa
AR072510A1 (es) Derivados de triazinas y de uracilos, su preparacion y su aplicacion en terapeutica humana
UY39676A (es) Moduladores de sting (estimulador de genes de interferón)
PY2039849A (es) Derivados de 3,6-diamino-piridazin-3-ilo, composiciones farmacéuticas que los contienen y sus usos como agentes proapoptóticos
CR20150419A (es) Derivados sustituidos del ácido bisfenil butanóico fosfónico como inhibidores de la nep
ECSP22030481A (es) Compuestos de amina cíclica activos como plaguicidas
MX2020011339A (es) Polímero catiónico y uso para suministro de biomolecúla.
UY39694A (es) Novedosos compuestos útiles como agonistas de sting y sus usos
UY36416A (es) 1-[2-(aminometil)bencil]-2-tioxo-1,2,3,5-tetrahidro-4h-pirrolo[3,2-d]pirimidin-4-onas como inhibidores de la mieloperoxidasa
AR113958A1 (es) Macrociclos a como inhibidores de pde1
PY2201650A (es) Nuevos derivados de espirociclohexano, composiciones farmacéuticas que los contienen y sus usos como inhibidores antiapoptóticos
UY39865A (es) Pirazin-2-carboxamidas sustituidas como inhibidores de hpk1 para el tratamiento del cáncer
MX2024003569A (es) Ciclohexil beta-hidroxi alquil aminas y usos médicos de estas.
CO2024000832A2 (es) Inhibidores de transglutaminasas
CO2023017151A2 (es) Inhibidores de ripk1 de nicotinamida